FGF-19 analogues for the treatment of metabolic dysfunction-associated steatohepatitis: a systematic review and meta-analysis

被引：0
|
作者：
Khalil, Samira Mohamad [1 ]
Souza, Matheus [2 ]
de Oliveira, Fabiana Dolovitsch [3 ]
Buarque de Santana Sato, Emmily Daiane [4 ]
Meine, Gilmara Coelho [5 ]
机构：
[1] Univ Buenos Aires, Buenos Aires, DF, Argentina
[2] Univ Fed Rio De Janeiro, Rio De Janeiro, Brazil
[3] Univ Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, Brazil
[4] Pontificia Univ Catolica Campinas, Campinas, Brazil
[5] Univ Feevale, Novo Hamburgo, Brazil
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-244
引用
收藏
页码：S618 / S619
页数：2
相关论文
共 50 条
  • [41] Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review
    Ghazanfar, Haider
    Javed, Nismat
    Qasim, Abeer
    Zacharia, George Sarin
    Ghazanfar, Ali
    Jyala, Abhilasha
    Shehi, Elona
    Patel, Harish
    CANCERS, 2024, 16 (06)
  • [42] Treating metabolic dysfunction-associated steatohepatitis: The fat-trimming FGF21 approach
    Li, Xiaokun
    Rao, Zhiheng
    Hu, Wenhao
    Lu, Weiqin
    Luo, Yongde
    OBESITY REVIEWS, 2025, 26 (03)
  • [43] Cardiovascular outcomes post bariatric surgery in patients with metabolic dysfunction-associated steatotic liver disease - A systematic review and meta-analysis
    Kumar, Jai
    Mohsin, Sana
    Hasan, Misha
    Bilal, Abdur Raheem
    Ali, Kumail Mustafa
    Umer, Ahmed
    Hadi, Dua Zehra Mohammad
    Nandlal, Sanjna
    Kumar, Sarwan
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (01)
  • [44] EFFICACY AND SAFETY OF RESMETIROM IN TREATING PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): A SYSTEMATIC REVIEW AND META-ANALYSIS
    Ekreer, Moad
    Al Hayek, Mohammad
    Alhateem, Mohamed Salah
    Khashan, Abdallah
    Abeedah, Raja
    Aghneewah, Omar
    Abduljawad, Fatimah Alzahra
    Elhadi, Muhammed
    HEPATOLOGY, 2024, 80
  • [45] Association between the severity of metabolic dysfunction-associated fatty liver disease and the risk of colorectal neoplasm: a systematic review and meta-analysis
    Yunqing Zeng
    Ruyue Cao
    Ziwen Tao
    Yanjing Gao
    Lipids in Health and Disease, 21
  • [46] Association between the severity of metabolic dysfunction-associated fatty liver disease and the risk of colorectal neoplasm: a systematic review and meta-analysis
    Zeng, Yunqing
    Cao, Ruyue
    Tao, Ziwen
    Gao, Yanjing
    LIPIDS IN HEALTH AND DISEASE, 2022, 21 (01)
  • [47] The Effects of Testosterone Replacement Therapy in Adult Men With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-analysis
    Mahmoud, Maya
    Kawtharany, Hassan
    Awali, Mohamed
    Mahmoud, Nadine
    Mohamed, Islam
    Syn, Wing-Kin
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2025, 16 (01)
  • [48] Growth hormone augmentation in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials
    Mohamed, Islam
    Gautam, Misha
    Abosheaishaa, Hazem
    Hussain, Sophia
    Kumar, Kopal
    Kotak, Anaya
    Baugh, Macy
    Qureshi, Raabia
    Jaber, Fouad
    Dahiya, Dushyant Singh
    Alba, Laura
    Duong, Nikki
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (11) : 1259 - 1266
  • [49] Metabolic dysfunction-associated steatotic liver disease and the risk of mortality in individuals with type 2 diabetes: a systematic review and meta-analysis
    Wongtrakul, Wasit
    Charatcharoenwitthaya, Natthinee
    Charatcharoenwitthaya, Phunchai
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (04) : 351 - 358
  • [50] Metabolic Bariatric Surgery for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Scoping Review of Biomarker and Histology Changes
    Shah, A.
    Mohammadi, A.
    Haq, A.
    Walji, D.
    Zevin, B.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2025, 73 (01) : 297 - 299
12345